Saving changes...

Done

Error

When Writing a Script Just Isn’t Enough: Strategies to Overcome Barriers Associated with Poor Asthma Control in Older Adults

When Writing a Script Just Isn’t Enough: Strategies to Overcome Barriers Associated with Poor Asthma Control in Older Adults

When Writing a Script Just Isn’t Enough: Strategies to Overcome Barriers Associated with Poor Asthma Control in Older Adults

Dr. Tolly Epstein (MD MS FAAAAI), Dr. Dennis K. Ledford (MD FAAAAI), and Dr. Carol A. Saltoun
Dr. Tolly Epstein (MD MS FAAAAI), Dr. Dennis K. Ledford (MD FAAAAI), and Dr. Carol A. Saltoun
on behalf of American Academy of Allergy Asthma & Immunology

$15.00 $ 15.00 $ 15.00

$15.00 $ 15.00 $ 15.00

$ 15.00 $ 15.00 $ 15.00
$ 15.00 $ 15.00 $ 15.00
Normal Price: $15.00 $15.00

Review:

Launch date: 02 Jul 2018
Expiry Date:

Last updated: 22 Aug 2018

Reference: 190500

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

Provide participants with evidence-based approaches to improve asthma control in older adults, with consideration for both medication and non-medication related strategies. Approaches to distinguish asthma symptoms from co-morbid illness, as well as strategies to safely and effectively manage older asthmatics with particular physical and cognitive co-morbidities, including depression and dementia, will be discussed. In addition, strategies to discuss and achieve shared goals, with consideration for financial and side-effect related concerns, will be presented. Non-medication therapeutic approaches such as pulmonary rehabilitation will also be discussed.

Objectives

Describe diagnostic and therapeutic approaches to the elderly asthmatic
Upon completion of this session, participants should be able to describe diagnostic and therapeutic approaches to the elderly asthmatic
Describe the effect of financial concerns and medication related side-effects on asthma management in the elderly
Upon completion of this session, participants should be able to describe the effect of financial concerns and medication related side-effects on asthma management in the elderly.
Explain how non-pharmaceutical interventions including pulmonary rehabilitation impact the elderly asthmatic
Upon completion of this session, participants should be able to explain how non-pharmaceutical interventions including pulmonary rehabilitation impact the elderly asthmatic.
Dr. Tolly Epstein (MD MS FAAAAI), Dr. Dennis K. Ledford (MD FAAAAI), and Dr. Carol A. Saltoun

Author Information Play Video Bio

Dr. Tolly Epstein (MD MS FAAAAI), Dr. Dennis K. Ledford (MD FAAAAI), and Dr. Carol A. Saltoun
on behalf of American Academy of Allergy Asthma & Immunology

Dr. Tolly Epstein, MD MS FAAAAI, University of Cincinnati, Carmel, IN

Dr. Dennis K. Ledford, MD FAAAAI, University of South Florida, Tampa, FL

Dr. Carol A. Saltoun, MD FAAAAI, Northwestern University - Feinberg School of Medicine, Chicago, IL

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 1.25 Credits
  • California Board of Registered Nursing (CBRN)
  • 1.25 Hours

Faculty and Disclosures

Tolly Epstein, MD FAAAAI

Tolly Epstein, MD FAAAAI

No Conflict
Dennis K. Ledford, MD FAAAAI

Dennis K. Ledford, MD FAAAAI

Potential Conflict

Research Grant: Circassia
Research Grant: Teva
Research Grant: Forest
Consultant: Shook Hardy Bacon
Consultant: Saieva and Stine
Consultant, research grant, speaker:
Genentech
Speaker: Meda Pharmaceutical
Research Grant: Merck
Speaker: Allergy and Asthma Network
Consultant: Reminger Law Firm
Consultant: Wicker, Smith, O'Hara, McCoy
and Ford
Advisory Board: Boehringer Ingelheim
Advisory Board: AstraZeneca
AstraZeneca (Ongoing): Speaker
Chugai (Ongoing): Data Safety Committee
Fowler White Burnett: Expert Witness
Meda (Ongoing): Speaker
Merck: Consultant
Merck (Ongoing): Speaker
Novartis: Advisory Board
Richard Benjamin Wilkes (Ongoing): Expert
Witness
TEVA (Ongoing): Speaker
Carol A. Saltoun, MD FAAAAI

Carol A. Saltoun, MD FAAAAI

No Conflict

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error